Prevalence of xerostomia in women during breast cancer chemotherapy
ABSTRACT Objective: To identify the prevalence of xerostomia in women undergoing chemotherapy for breast cancer. Method: Prospective cohort with 27 women who underwent up to 16 sessions of intravenous chemotherapy. Data collection was performed at the outpatient clinic of a university hospital in the city of São Paulo, where two forms were applied before the start of treatment and the Xerostomia Inventory before and after each chemotherapy session. Results: Complaints of dry mouth were present in 48.1% of women before chemotherapy, and they were approximately 28 times more likely to develop dry mouth during treatment. It was observed that the use of antiemetics contributed to the occurrence of xerostomia, and the anti-ulcerous were presented as a protective factor. Conclusion: The study identified both a high prevalence of xerostomia regardless of the chemotherapy used and the need to create protocols to improve the quality of life of these patients.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Enfermagem
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672020001600189 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0034-71672020001600189 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0034-716720200016001892020-09-17Prevalence of xerostomia in women during breast cancer chemotherapyPinto,Vânia LopesFustinoni,Suzete MariaNazário,Afonso Celso PintoFacina,GilElias,Simone Xerostomia Breast Neoplasms Drug Therapy Women Antineoplastic Agents ABSTRACT Objective: To identify the prevalence of xerostomia in women undergoing chemotherapy for breast cancer. Method: Prospective cohort with 27 women who underwent up to 16 sessions of intravenous chemotherapy. Data collection was performed at the outpatient clinic of a university hospital in the city of São Paulo, where two forms were applied before the start of treatment and the Xerostomia Inventory before and after each chemotherapy session. Results: Complaints of dry mouth were present in 48.1% of women before chemotherapy, and they were approximately 28 times more likely to develop dry mouth during treatment. It was observed that the use of antiemetics contributed to the occurrence of xerostomia, and the anti-ulcerous were presented as a protective factor. Conclusion: The study identified both a high prevalence of xerostomia regardless of the chemotherapy used and the need to create protocols to improve the quality of life of these patients.info:eu-repo/semantics/openAccessAssociação Brasileira de EnfermagemRevista Brasileira de Enfermagem v.73 suppl.4 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672020001600189en10.1590/0034-7167-2019-0785 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Pinto,Vânia Lopes Fustinoni,Suzete Maria Nazário,Afonso Celso Pinto Facina,Gil Elias,Simone |
spellingShingle |
Pinto,Vânia Lopes Fustinoni,Suzete Maria Nazário,Afonso Celso Pinto Facina,Gil Elias,Simone Prevalence of xerostomia in women during breast cancer chemotherapy |
author_facet |
Pinto,Vânia Lopes Fustinoni,Suzete Maria Nazário,Afonso Celso Pinto Facina,Gil Elias,Simone |
author_sort |
Pinto,Vânia Lopes |
title |
Prevalence of xerostomia in women during breast cancer chemotherapy |
title_short |
Prevalence of xerostomia in women during breast cancer chemotherapy |
title_full |
Prevalence of xerostomia in women during breast cancer chemotherapy |
title_fullStr |
Prevalence of xerostomia in women during breast cancer chemotherapy |
title_full_unstemmed |
Prevalence of xerostomia in women during breast cancer chemotherapy |
title_sort |
prevalence of xerostomia in women during breast cancer chemotherapy |
description |
ABSTRACT Objective: To identify the prevalence of xerostomia in women undergoing chemotherapy for breast cancer. Method: Prospective cohort with 27 women who underwent up to 16 sessions of intravenous chemotherapy. Data collection was performed at the outpatient clinic of a university hospital in the city of São Paulo, where two forms were applied before the start of treatment and the Xerostomia Inventory before and after each chemotherapy session. Results: Complaints of dry mouth were present in 48.1% of women before chemotherapy, and they were approximately 28 times more likely to develop dry mouth during treatment. It was observed that the use of antiemetics contributed to the occurrence of xerostomia, and the anti-ulcerous were presented as a protective factor. Conclusion: The study identified both a high prevalence of xerostomia regardless of the chemotherapy used and the need to create protocols to improve the quality of life of these patients. |
publisher |
Associação Brasileira de Enfermagem |
publishDate |
2020 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672020001600189 |
work_keys_str_mv |
AT pintovanialopes prevalenceofxerostomiainwomenduringbreastcancerchemotherapy AT fustinonisuzetemaria prevalenceofxerostomiainwomenduringbreastcancerchemotherapy AT nazarioafonsocelsopinto prevalenceofxerostomiainwomenduringbreastcancerchemotherapy AT facinagil prevalenceofxerostomiainwomenduringbreastcancerchemotherapy AT eliassimone prevalenceofxerostomiainwomenduringbreastcancerchemotherapy |
_version_ |
1756377244632088576 |